Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.

Fukami K, Yamagishi S, Sakai K, Kaida Y, Adachi T, Ando R, Okuda S.

Rejuvenation Res. 2013 Dec;16(6):460-6. doi: 10.1089/rej.2013.1459.

2.

Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.

Fukami K, Yamagishi S, Sakai K, Kaida Y, Yokoro M, Ueda S, Wada Y, Takeuchi M, Shimizu M, Yamazaki H, Okuda S.

J Cardiovasc Pharmacol. 2015 Mar;65(3):289-95. doi: 10.1097/FJC.0000000000000197.

PMID:
25636076
3.

Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.

Adachi T, Fukami K, Yamagishi S, Kaida Y, Ando R, Sakai K, Adachi H, Otsuka A, Ueda S, Sugi K, Okuda S.

Nephrology (Carlton). 2012 Nov;17(8):689-94. doi: 10.1111/j.1440-1797.2012.01642.x.

PMID:
22804770
4.

Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.

Higuchi T, Abe M, Yamazaki T, Mizuno M, Okawa E, Ando H, Oikawa O, Okada K, Kikuchi F, Soma M.

Nutrients. 2014 Dec 22;6(12):5992-6004. doi: 10.3390/nu6125992.

5.

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.

J Am Soc Nephrol. 2005 Dec;16(12):3687-93. Epub 2005 Nov 9.

6.

Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.

Cruciani RA, Dvorkin E, Homel P, Malamud S, Culliney B, Lapin J, Portenoy RK, Esteban-Cruciani N.

J Pain Symptom Manage. 2006 Dec;32(6):551-9.

PMID:
17157757
7.

The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients.

Suchitra MM, Ashalatha VL, Sailaja E, Rao AM, Reddy VS, Bitla AR, Sivakumar V, Rao PV.

Saudi J Kidney Dis Transpl. 2011 Nov;22(6):1155-9.

8.

Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.

Shakeri A, Tabibi H, Hedayati M.

Hemodial Int. 2010 Oct;14(4):498-504. doi: 10.1111/j.1542-4758.2010.00476.x. Epub 2010 Aug 31.

PMID:
20812958
9.

Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.

Csiky B, Bene J, Wittmann I, Sulyok E, Melegh B.

Int Urol Nephrol. 2013 Jun;45(3):847-55. doi: 10.1007/s11255-012-0209-x. Epub 2012 Jun 10.

PMID:
22684763
10.

Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.

Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R.

Artif Organs. 2013 Jul;37(7):E114-22. doi: 10.1111/aor.12078. Epub 2013 May 2.

PMID:
23635017
11.

L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.

Csiky B, Nyul Z, Tóth G, Wittmann I, Melegh B, Rauh M, Rascher W, Sulyok E.

Exp Clin Endocrinol Diabetes. 2010 Nov;118(10):735-40. doi: 10.1055/s-0030-1261912. Epub 2010 Jul 23.

PMID:
20658442
12.

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.

Fukami K, Yamagishi S, Sakai K, Nasu M, Okuda S.

Clin Kidney J. 2014 Oct;7(5):470-4. doi: 10.1093/ckj/sfu082. Epub 2014 Jul 29.

13.

The role of oral L-carnitine therapy in chronic hemodialysis patients.

Sabry AA.

Saudi J Kidney Dis Transpl. 2010 May;21(3):454-9.

14.

Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.

Bene J, Csiky B, Wittmann I, Sulyok E, Melegh B.

Ren Fail. 2012;34(5):555-8. doi: 10.3109/0886022X.2012.664509. Epub 2012 Mar 15.

PMID:
22417076
15.

Anemia and carnitine supplementation in hemodialyzed patients.

Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Hörl WH, Kovarik J.

Kidney Int Suppl. 1999 Mar;69:S93-106.

PMID:
10084293
16.

Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.

Jiang J, Chen P, Chen J, Yu X, Xie D, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Zhang P, Yang X, Zhang Y, Zhang Y, Liang X, Zhang Z, Lin Q, Yu Y, Miyata T, Tian J, Liang M, Luo W, Xu X, Hou F.

Atherosclerosis. 2012 Sep;224(1):187-94. doi: 10.1016/j.atherosclerosis.2012.06.022. Epub 2012 Jul 13.

PMID:
22857897
17.

Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis.

Sakai K, Fukami K, Yamagishi S, Kaida Y, Adachi T, Ando R, Manabe R, Otsuka A, Sugi K, Ueda S, Okuda S.

Rejuvenation Res. 2013 Jun;16(3):200-5. doi: 10.1089/rej.2012.1399.

PMID:
23488553
18.

Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.

Naini AE, Sadeghi M, Mortazavi M, Moghadasi M, Harandi AA.

Saudi J Kidney Dis Transpl. 2012 May;23(3):484-8.

19.

Nutritional effects of carnitine supplementation in hemodialysis patients.

Chazot C, Blanc C, Hurot JM, Charra B, Jean G, Laurent G.

Clin Nephrol. 2003 Jan;59(1):24-30.

PMID:
12572927
20.

Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.

Tabibi H, Hakeshzadeh F, Hedayati M, Malakoutian T.

J Ren Nutr. 2011 Nov;21(6):485-91. doi: 10.1053/j.jrn.2011.01.001. Epub 2011 Mar 25.

PMID:
21439850

Supplemental Content

Support Center